Gefitinib
- Product NDC
- 50742-366
- 11-digit product format
- 507420366
- Labeler code
- 50742
- Product ID
- 50742-366_932e3701-75ae-438f-bb6a-2c2662c73ee5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gefitinib
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA211591
- Marketing category
- ANDA
- Marketing start
- 2023-04-27
- Substance
- GEFITINIB
- Active strength
- 250 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gefitinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GEFITINIB | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | S65743JHBS |
| Rxcui | 349472 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50742-366-30 | Gefitinib | 30 in 1 BOTTLE | TABLET, COATED | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-366 | GEFITINIB TABLET, COATED [INGENUS PHARMACEUTICALS, LLC] | 3 | Current NDC, 1 package rows | 20231229_6402435f-9f6a-4f02-91a2-6267d783fa78.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50742-366-30 | 50742036630 | 30 TABLET, COATED in 1 BOTTLE (50742-366-30) | 2023-04-27 | No | No | Current |